Close

Jefferies Lowers Numbers on Celgene (CELG); Two Possible Pathways

June 22, 2012 10:58 AM EDT Send to a Friend
Jefferies maintains a 'Buy' on Celgene (NASDAQ: CELG) price target of $75.00 (from $85.00).

Analyst, Thomas Wei, said, "CELG ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login